Revalia Bio
PrivateLast Round
Grant
Dec 5, 2025
Total Funding Raised
$46.2M
Momentum
Top 5%
of companies Caplight tracks
Company Overview
Revalia Bio is a biotechnology company that provides a 'Human Data Trials' platform, enabling drug developers to test therapeutics on functional human organs obtained from deceased donors.
Sector
Healthcare & Life Sciences
Verticals
Drug Discovery, Biotechnology, Biotech Equipment, Healthcare Analytics
Business Model
B2B
Customer Profile
Services & Consulting, Subscription SaaS, Data as a Service
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Revalia Bio Comparables
Compare Revalia Bio with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Bexorg | 83% | |
| AnaBios | 78% | |
| Hesperos Inc. | 74% |
Revalia Bio Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Dec 5, 2025 | ||||
| Seed | Sep 4, 2025 | ||||
| Pre Seed | Oct 17, 2024 |
Key People
Founding team and executive leadership
Revalia Bio Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Connecticut Innovations | Seed, Pre Seed |
| Sierra Ventures | Seed |
| America's Frontier Fund | Seed |
| AFF | Seed |
| Pamir Ventures | Seed |
| BoxOne Ventures | Seed |
| ARPA-H | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 21, 2026
Monthly visitors increased 35% MoM.
- Aug 16, 2026
Grew 23% QoQ, from 30 to 37 employees.
Recent news
Latest coverage and updates
- hiresSep 16, 2026
Revalia Bio, Inc. hired Starsiak as president and CEO on Sep 1st '26.
Revalia Bio Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Revalia Bio's valuation, stock price, and market status.
Is Revalia Bio a public or private company?
Revalia Bio is a private company.
What is the current stock price of Revalia Bio?
Revalia Bio is a private company with no public stock price. No recent secondary market data is available.
How much is Revalia Bio worth (valuation)?
Valuation information for Revalia Bio is not publicly available.
Can I buy Revalia Bio stock?
Revalia Bio shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Revalia Bio's last funding round?
Revalia Bio's most recent funding round was Grant on December 5, 2025.
Who are the main investors in Revalia Bio?
Key investors in Revalia Bio include Sierra Ventures, America's Frontier Fund, AFF, ARPA-H.
Will Revalia Bio IPO soon?
No public IPO plans have been announced for Revalia Bio.
How can I track Revalia Bio secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Revalia Bio's secondary market activity and sign up for updates.